Patents
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
04/2009
04/08/2009EP1814846B1 11beta-hsd1 inhibitors
04/08/2009CN101402594A Substituted benzene dithiol metal complex and photoabsorption pigment composition containing the same
04/08/2009CN101402575A Flame-retardant compound, flame-retardant particle, resin composition and resin formed body
04/08/2009CN100475798C Sulfonate derivatives and the use therof as latent acids
04/08/2009CN100475788C Process for purifying mesotrione
04/08/2009CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor
04/07/2009US7514582 Cardiac ANTIARRHYTHMIA AGENTS; atrial fibrillation or atrial flutter; Kv1.5 potassium channel blockers;
04/07/2009CA2362833C Phenylalaninol derivatives
04/02/2009WO2009040590A1 Complex product with advanced assimilation efficacy for humans and its utilization
04/02/2009WO2008149141A3 Novel process
04/02/2009US20090088592 Aromatic vinyl ether compounds
04/02/2009US20090088582 Crosslinked carbon nanotube
04/02/2009US20090088570 Organic electroluminescent device
04/02/2009CA2700727A1 Complex product with advanced assimilation efficacy for humans and its utilization
04/01/2009EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases
04/01/2009EP2041079A1 Arylsulfonyl naphthalene derivatives and uses thereof
04/01/2009EP1660431B1 Phenoxyacetic acid derivatives
04/01/2009CN101397268A Method for preparing amino benzenes derivates N-monoalkyl compounds
04/01/2009CN101397267A Technology for preparing di-n-octyl sulphoxide
04/01/2009CN100473667C Photoinitiator, novel compound and photocurable composition
03/2009
03/31/2009US7511144 Reverse hydroxamic acid derivatives
03/26/2009WO2009038463A1 Uv absorbing compounds
03/26/2009US20090079343 Organic electroluminescent device
03/25/2009CN101395104A An improved process for the preparation of armodafinil
03/24/2009US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity
03/24/2009US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione
03/24/2009US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery
03/19/2009US20090076285 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound
03/19/2009US20090076178 Cross-Linkable Bi-Sulphonyl Derivatives And Their Uses For Preparing Ion-Exchanging Membranes
03/19/2009US20090075952 Nitroderviatives as drugs for diseases having an inflammatory basis
03/19/2009US20090074746 Compounds to treat alzheimer's disease
03/18/2009EP2035370A2 Tetralin and indane derivatives and uses thereof
03/18/2009EP1805129B1 (biphenyl) carboxylic acids and derivatives thereof
03/18/2009CN101389597A Carbonates of fenicol antibiotics
03/17/2009US7504537 osteoarthritis or rheumatoid arthritis
03/17/2009US7504528 Merocyanine derivatives for cosmetic use
03/17/2009US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/12/2009WO2009030752A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them
03/12/2009US20090069561 Click chemistry route to triazole dendrimers
03/12/2009US20090069521 Novel Compound, Polymer, and Radiation-Sensitive Composition
03/12/2009US20090069428 Catalytic antioxidants and methods of use
03/12/2009US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt
03/12/2009CA2698304A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them
03/11/2009EP2033515A1 Method for improved utilisation of the production potential of transgenic plants
03/11/2009EP1940782B1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors
03/11/2009EP1831405B1 Composition for the treatment of leather
03/11/2009CN101384547A Process for the crystallisation of mesotrione
03/11/2009CN101384170A Malononitrile compounds
03/11/2009CN100467446C Production technology and device of paranminophenyl-beta-hydroxyethyl sulfone sulfate
03/10/2009US7501538 Erythropoietin receptor activators; inducing red blood cell production and maturation
03/10/2009US7501535 Silicon and six or seven carbon terminated polypropionate stereotetrad and steropentads for synthesis of natural compounds
03/10/2009CA2345069C 2-phenylpyran-4-one derivatives
03/05/2009WO2009027004A1 Thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]phenyl}carbonyl)cyclohexane-1,3-dione
03/05/2009WO2009008905A4 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062285 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009CA2697465A1 Thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]phenyl}carbonyl)cyclohexane-1,3-dione
03/04/2009EP2030968A2 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof
02/2009
02/26/2009WO2009025791A2 Purification of armodafinil
02/26/2009WO2009024863A2 Process for the preparation of modafinil enantiomers
02/26/2009US20090054655 Process for the Production of Organic Oxides
02/26/2009US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
02/26/2009US20090053612 Electrolytic solutions and battery
02/25/2009CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
02/25/2009CN101372467A Bridging compound having N,N-dialkylamino and dye compound used thereby
02/25/2009CN100463901C Alpha-ketoamide derivative, and production method and use thereof
02/24/2009US7495022 α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors
02/24/2009CA2247820C Functionalized nanotubes
02/19/2009WO2009022681A1 Positive resist composition, pattern forming method using the composition, and compound used in the composition
02/19/2009WO2009005110A3 Halogen-containing organosulfur compound and use thereof
02/18/2009CN101367748A Amide derivatives, process for production of the same, and method for application thereof as insecticide
02/18/2009CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/17/2009US7491748 e.g. (1) 3-(2-((naphthalen-1-ylmethyl)carbamoyl)-4-(2-methylphenoxymethyl)phenyl)propanoic acid; prostaglandin (PGE2) receptor ligand; analgesic, anticarcinogenic agent, antiallergen; neurodegenerative diseases
02/17/2009US7491747 4-(Arylthio)- or (4-heteroarylthio)butyric acid derivatives that may be used in the treatment of dyslipidaemia, atherosclerosis and diabetes
02/17/2009US7491705 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma
02/17/2009CA2157143C Alkylbenzoylguanidine derivatives
02/12/2009WO2009018824A1 Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders
02/12/2009US20090042973 Inhibitors of aspartyl protease
02/12/2009US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
02/12/2009US20090042907 Bicyclic aromatic sulfinyl derivatives
02/12/2009US20090042114 Halogenated oxime derivatives and the use therof as latent acids
02/11/2009CN101362712A P-aminophenyl-beta-hydroxyethyl sulfone preparation method
02/05/2009US20090036632 Polyarylene and Process for Producing the Same
02/05/2009US20090036535 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
02/04/2009EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
02/04/2009EP1565422B1 Vitamin d receptor modulators
02/04/2009CN100457708C Interfacial method of preparing ester-substituted diaryl carbonates
01/2009
01/29/2009WO2009014268A1 Fluorine-containing organosulfur compound and pesticidal composition comprising the same
01/29/2009US20090029099 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
01/28/2009CN101353313A Process to produce oxazolidinones
01/27/2009US7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant
01/27/2009US7482484 Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia
01/27/2009US7482302 triethylammonium (4-chlorophenylsulfonyl)difluoromethanesulfonate used for acid catalysts, ion exchange membranes
01/27/2009CA2346796C Benzoylcyclohexanediones, process for their preparation and their use as herbicides and plant growth regulators
01/22/2009WO2009010156A2 Substituted phenylpropoargyl compounds, methods for the production thereof, and use of same as herbicides and plant growth regulators
01/22/2009US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections
01/21/2009EP2017264A1 Substituted phenyl propargyl compounds, method for their manufacture and their use as herbicides and plant growth regulators
01/21/2009CN100453530C Compounds and methods for inhibition of expression of VCAM-1
01/21/2009CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 159